sarepta

FDA Sarepta Drug Approval Controversy
Newsletters

Does the FDA need to slow its drug approval roll?

By
January 22, 2020
Sarepta Stock Roche Deal
Health

Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal

By
December 23, 2019
Duchenne Sarepta FDA
Newsletters

FDA Approves Sarepta Duchenne Drug in Stunning Reversal

By
December 14, 2019
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health

Why Sarepta Stock Skyrocketed 40% Today

By
June 19, 2018
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health

This Controversial Biotech May Yet Defy Its Skeptics

By
September 6, 2017
A logo is seen in front of the entrance at the headquarters of French drugmaker Sanofi in Paris
Health

Drug Giant Sanofi May Be Getting Ready to Buy Up This Rare Disease Company

By
April 28, 2017
Gilead Just Paid $125 Million to Nab a Big Market Advantage
Health

Gilead Just Paid $125 Million to Nab a Big Market Advantage

By
February 21, 2017
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health

Drug Company Hits Pause on Launching an $89,000 Muscular Dystrophy Drug After Backlash

By
February 13, 2017
This Pharma Company Is Selling a Decades-old Drug to Treat Muscular Dystrophy for $89,000
Health

This Pharma Company Is Selling a Decades-old Drug to Treat Muscular Dystrophy for $89,000

By
February 10, 2017
Sarepta Therapeutics New Global Headquarters
Health

Insurers are Rebelling Against the FDA’s Most Controversial 2016 Drug Approval

By
December 14, 2016
Trading On The Floor Of The NYSE As U.S. Stocks Slide Amid Speculation On Tighter Monetary Policy
Health

Why This Controversial Biotech Stock Just Soared More Than 88%

By
November 12, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health

The FDA’s Most Controversial Drug Approval of the Year Just Hit a Huge Snag

By
October 7, 2016
Conversation on Child Cures
Health

The FDA Just Made Its Most Controversial Drug Approval of the Year

By
September 19, 2016
483106863
Health

This Drug Company’s Shares Are Up 20% Today

By
May 25, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health

This Rare Children’s Disease Drug Is Pitting Patients Against the FDA

By
April 26, 2016

Most Popular